Catalyst Wire Dossier Catalyst Wire Dossier

Tivoli DES

· Essen Technology (Beijing) Co., Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Tivoli DES, covering 2013-02-21 to 2013-02-21. Get the full timeline:

Most recent: Clinical Trial Update: Evaluate Safety And Effectiveness Of The Tivoli® DES and The Firebird2® DES For Treatment Coronary Revascularization [NA]

See pricing